Evidence map›Paper›PMID 32118511›Full record

ArticleHuman vaccines & immunotherapeutics2020

Protection of outbred mice against a vaginal challenge by a

Sukumar Pal, Salvador Fernando Ausar, Delia F Tifrea, Chunmei Cheng, Scott Gallichan, Violette Sanchez, Luis M de la Maza, Lucian Visan

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Baicalin relievesMolecular medicine reports · 2021
    Article
  4. Article
  5. Expert review of vaccines · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Sukumar PalDepartment of Pathology and Laboratory Medicine, University of California , Irvine, CA, USA.
Salvador Fernando AusarBioprocess Research and Development, Sanofi Pasteur , Toronto, Ontario, Canada.
Delia F TifreaDepartment of Pathology and Laboratory Medicine, University of California , Irvine, CA, USA.
Chunmei ChengDepartment of Pathology and Laboratory Medicine, University of California , Irvine, CA, USA.
Scott GallichanAnalytical Research and Development Department, Sanofi Pasteur , Toronto, Ontario, Canada.
Violette SanchezResearch & Non Clinical Safety Department, Sanofi Pasteur , Marcy l'Etoile, France.
Luis M de la MazaDepartment of Pathology and Laboratory Medicine, University of California , Irvine, CA, USA.
Lucian VisanResearch & Non Clinical Safety Department, Sanofi Pasteur , Marcy l'Etoile, France.
University of California, Irvine · USSanofi (Canada) · CASanofi (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Chlamydia InfectionsChlamydia trachomatisAnimalsAntibodies, BacterialBacterial Outer Membrane ProteinsBacterial VaccinesFemaleMicePhosphatesSerogroupAntibodies, BacterialBacterial Outer Membrane ProteinsBacterial VaccinesPhosphatesaluminum hydroxide adjuvantChlamydia trachomatisIFN-γneutralizing antibodyoutbreed CD-1 micerecombinant major outer membrane proteinsubunit vaccine

Identifiers

PMID32118511
PMCPMC7644203
OpenAlexW3009237397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.